Skip to main content
OpenTrials

Clinical trial condition

Paraneoplastic Syndromes, Nervous System

Explore clinical trials studying Paraneoplastic Syndromes, Nervous System. Study availability and eligibility vary by location and protocol.

307 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

Paraneoplastic Syndromes, Nervous System trial results

Recruiting

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

NCT06463587

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Arizona Neuroscience Research, LLC Phoenix, Arizona, United States
  • Advanced Neurosciences Research LLC Longmont, Colorado, United States
  • University of Connecticut Health Center - Department of Medicine Farmington, Connecticut, United States
  • The George Washington University Medical Faculty Associates Foggy Bottom South Pavilion Washington D.C., District of Columbia, United States
View all 153 locations
View Trial Details
Recruiting

A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis

NCT07501702

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • Neurology Offices Boca Raton, Florida, United States
  • SFM Clinical Reseach, LLC Boca Raton, Florida, United States
  • Homestead Associates in Research Homestead, Florida, United States
  • UF Health Jacksonville Respiratory Therapy (PFT and DLCO) Jacksonville, Florida, United States
View all 28 locations
View Trial Details
Recruiting

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

NCT06680037

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, B-cell Mediated Autoimmune Disorders, +28 more
Locations
  • TG Therapeutics Investigational Trial Site La Jolla, California, United States
  • TG Therapeutics Investigational Trial Site Ann Arbor, Michigan, United States
  • TG Therapeutics Investigational Trial Site Omaha, Nebraska, United States
  • TG Therapeutics Investigational Trial Site New York, United States
View Trial Details
Recruiting

Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod

NCT07072988

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • CHU de Nice Nice, Alpes-Maritimes, France
  • Hôpital Henri Mondor Créteil, France
  • Hôpital Raymond Pointcarré Garches, France
  • CHU de Grenoble Grenoble, France
View Trial Details
Recruiting

Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)

NCT07215650

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Huashan Hospital Affiliated to Fudan University Shanghai, Shanghai Municipality, China
  • Union Hospital Affiliated to Fujian Medical University Fuzhou, Fujian, China
  • The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine Guangzhou, Guangdong, China
  • The Third Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
View Trial Details
Recruiting

Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Rozanolixizumab)

NCT07570589

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • CHU de NICE Nice, Alpes-maritimes, France
  • CHu d'Angers Angers, France
  • Ch de Boulogne sur Mer Boulogne-sur-Mer, France
  • Hôpital Henri Mondor Créteil, France
View Trial Details

Related conditions